$3.08 Billion is the total value of Alphabet Inc.'s 70 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
DXCM | Buy | Dexcom Inc | $537,484,000 | +42.2% | 1,050,595 | +49.2% | 17.44% | +91.0% |
SNOW | New | Snowflake Inccl a | $122,723,000 | – | 535,604 | +100.0% | 3.98% | – |
Buy | Benson Hill Inc | $49,588,000 | -53.9% | 15,352,271 | +4.1% | 1.61% | -38.0% | |
RLAY | Buy | Relay Therapeutics Inc | $46,953,000 | -2.3% | 1,568,753 | +0.3% | 1.52% | +31.3% |
New | Rani Therapeutics Hldgs Inc | $9,645,000 | – | 714,471 | +100.0% | 0.31% | – | |
New | Cue Health Inc | $174,000 | – | 27,000 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
DEXCOM INC | 20 | Q3 2023 | 17.4% |
Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
ALECTOR INC | 19 | Q3 2023 | 1.1% |
Lyft Inc | 18 | Q2 2023 | 51.9% |
QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
PX14A6G | 2024-05-24 |
PX14A6G | 2024-05-22 |
PX14A6G | 2024-05-16 |
144 | 2024-05-15 |
144 | 2024-05-15 |
4 | 2024-05-15 |
4 | 2024-05-14 |
144 | 2024-05-13 |
4 | 2024-05-13 |
PX14A6G | 2024-05-08 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.